Globus Medical completes enrollment for cervical disc clinical trial
The Secure-C device is designed to mimic the normal motion of the spine in order to alleviate pain and restore function as an alternative to fusion in the

The Secure-C device is designed to mimic the normal motion of the spine in order to alleviate pain and restore function as an alternative to fusion in the

The safety and efficacy of Strattera in the maintenance of attention-deficit hyperactivity disorder (ADHD) was demonstrated in one of the largest relapse prevention studies ever conducted in ADHD,

Under the terms of the agreement, NuVasive will acquire the Osteocel biologics business from Osiris for $35 million in cash at closing, plus additional milestone-based contingent payments not

In addition, the company issued to the investors, warrants to purchase 1.28 million shares of common stock at an exercise price of $0.65 per share. Tony Shum, chairman

Abilify is now indicated for the maintenance treatment of manic and mixed episodes associated with bipolar I disorder with or without psychotic features in pediatric patients (aged 10-17)

The study evaluated the outcome of 82 patients treated for chronic tendinosis using the Topaz MicroDebrider. Assessment of pain relief was monitored over a period of one to

Under terms of the agreement, Microbix will acquire the urokinase product and related assets for an upfront payment of $12 million plus an additional $5 million upon achievement

Mycamine will initially be available in the UK and across the European market shortly after this. David Denning of the University of Manchester said: “The approval of micafungin

Following the spin-off of the biotechnology company, Enzon will retain the current marketed products of Abelcet, Adagen, DepoCyt and Oncaspar, the rights to current PEG royalty revenues, including

The first of these patents covers the company’s HDL Selective Delipidation technology. HDL Selective Delipidation modifies naturally occurring HDL resulting in the creation of a substantially more effective